PetMed Express, Inc. (PETS)

Market Cap	48.09M -33.1%
Revenue (ttm)	186.96M -20.7%
Net Income	-64.87M
EPS	-3.12
Shares Out	21.37M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	85,437
Open	2.210
Previous Close	2.230
Day's Range	2.190 - 2.270
52-Week Range	1.570 - 4.320
Beta	0.79
Analysts	Strong Sell
Price Target	2.15 (-4.83%)
Earnings Date	Jun 9, 2026

About PETS

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthri...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1996
• Employees: 173
• Stock Exchange: NASDAQ
• Ticker Symbol: PETS
• Website: https://www.1800petmeds.com

Financial Performance

In fiscal year 2025, PetMed Express's revenue was $226.97 million, a decrease of -17.19% compared to the previous year's $274.10 million. Losses were -$6.27 million, -15.98% less than in 2024.

Analyst Summary

According to one analyst, the rating for PETS stock is "Strong Sell" and the 12-month stock price target is $2.15.

Price Target

$2.15

(-4.83% downside)

Analyst Consensus: Strong Sell